recognize that patient population was homogenous and high risk and thus
recognize the possible limitations of the generalizability of the study.
Authors also recognize that data collection asked limited questions
regarding risk factors and relied on patient's ability to self-report
risky behaviors and symptoms.
The ability to screen more frequently than every year relies on the
availability of nucleic acid amplification tests that can be used on
Estimates range from 10-40% of all inadequately treated patients with
Chlamydia infections will progress to PID.
Burstein GR. Incident Chlamydia trachomatis infections among inner-city
adolescent females. JAMA 1998; 260: 521-6.
Howell, MR, Quinn TC, Braithwhite W, Gaydos CA. Screening women for
Chlamydia trachomatis in family planning clinics. Sexually Transmitted
Diseases. 1998;25: 108-17.
Hillis S, Wasserheit, J. Screening for Chlamydia-A Key to the Prevention
of Pelvic Inflammatory Disease. New England Journal of Medicine.